and improving the social environment to reduce the prevalence of NCDs will be important in China.
These key findings indicate that various strategies for prevention and control of disease have not been implemented effectively in China. For tobacco control, although the WHO Framework Convention on Tobacco Control came into effect on Jan 8, 2006 in China, the relevant articles of this treaty have not been effectively implemented in the past 10 years or more, and the prevalence of smoking has not substantially dropped. 5 China needs to put into practice the call of the Chinese president for integrating health into all policies. 6 More importantly, disease control requires efforts at the province and local levels. Zhou and colleagues 1 describe the distribution of the age-standardised YLLs of 20 diseases at the province level. These findings are important for evaluation and promotion of local disease control strategies. However, at present, the geographical distribution pattern of some diseases by province level remains unstable; for example, the agestandardised YLLs for stroke in 2017 are not consistent with the province-level distribution of stroke in GBD 2013 3 and data from earlier local studies. 7, 8 The early studies showed a decline in geographical distribution of stroke mortality and morbidity from north to south. 7, 8 The GBD 2013 report indicated high stroke mortality in nine provinces located in the central and western areas of China.
3 By contrast, in the current GBD 2017 study, part of the country and across the northeast, northwest, and southwest regions. These inconsistencies are understandable owing to some changes in data and methods since the publication of GBD 2010. For example, mortality from ischaemic heart disease in China was on the rise in GBD 2010 and then steady in GBD 2013. 9 This issue caused debate among experts in cardiovascular disease and public health in China. 10 After correcting garbage coding allocation, mortality from ischaemic heart disease was shown to be on the rise in later GBD studies including this study by Zhou and colleagues.
How, therefore, should the China health and policy communities respond to these new findings? Discussion about the results would seem useful. For example, the estimated proportion of deaths attributable to tobacco use in GBD 2010 was 16·4% (95% uncertainty interval 12·8-19·9) 2 but the value for the same year in GBD 2017 was 23·5% (22·4-24·6).
1 Furthermore, the GBD 2017 estimates differed from results in other empirical surveys. 11 These differences in estimates of deaths attributable to tobacco smoking are worthy of further study and discussion.
We appreciate that the GBD study provides a systematic approach to estimating population mor tality, morbidity, and related risk factors and provides a comprehensive description of population health. Mastering the relevant methods of GBD and understanding and discussing the results of GBD are helpful to understand the distribution and changing trends of population health problems more deeply and comprehensively, and, at the same time, can also promote the further improvement of GBD methods. The process will contribute to further validation of data, optimisation of analysis strategies, obtaining optimal estimates, and facilitating policy advocacy to promote the implementation of disease control policies at the national and province levels.
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